• Davion Healthcare targets an initial US$ 100 million in acquisition financing for 2027, with scope to increase the target.
• Vienna Capital Partners will advise on financing structures under a non-exclusive agreement.
• The strategy targets multiple established, profitable, cash-generative healthcare and related services businesses, principally in the United States.
• Preferred funding is senior secured, non-convertible debt from institutional lenders to limit shareholder dilution.
• Financing would be arranged transaction by transaction; the aggregate target is not a committed credit facility.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DAVION HEALTHCARE PUBLIC LIMITED COMPANY published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611060730PRIMZONEFULLFEED1001302202) on November 06, 2026, and is solely responsible for the information contained therein.